Select Page

Speakers to date, subject to change as speakers are added and confirmed.

Sammy, Amerigo and Laura Basso, Italy
Family Panel
The Journey from No Hope, to Clinical Trials, and Entering Young Adulthood – Living Life to Its Fullest
Vicenza, Italy

 

Leslie Gordon, MD, PhD
Medical Director and Chair, Organizing Committee
FDA Biomarker Program – Progerin as a Biomarker for HGPS and Moderator: Progerin Biology and HGPS Model Systems
The Progeria Research Foundation, Brown University, Hasbro Children’s Hospital, Boston Children’s Hospital, and Harvard University

 

Vicente Andrés, PhD
Scientific Organizing Committee
Temporal, systemic and tissue-specific factors regulate lifespan extension in a new HGPS mouse model
CNIC, Spanish National Cardiovascular Research Center, Madrid, Spain

 

David Cory
Rare Disease Pharma and The Journey Towards Lonafarnib Approval
Eiger BioPharmaceuticals, Inc., Palo Alto, CA

 

Marie Gerhard-Herman, MD
Clinical Cardio-Neurovascular Panel
Brigham &Women’s Hospital, Boston

 

Monica Kleinman, MD
Current Treatment Trial Update
Boston Children’s Hospital

 

Giovanna Lattanzi, PhD
Progerin – interleukin 6 cross-talk in human and mouse cells: new insights into the accelerated ageing process
CNR Institute of Molecular Genetics, Bologna, Italy

 

David R. Liu, PhD
Precision Genome Editing and Progeria
Howard Hughes Medical Institute, Broad Institute, Harvard University

Leslie Smoot, MD
Clinical Cardio-Neurovascular Panel
Boston Children’s Hospital, Boston, MA 

 

Colin Stewart, PhD
Breaking the LINC to Treat Progeria
Institute of Medical Biology, Immunos, Singapore 

Judy Campisi, PhD
Scientific Organizing Committee
Moderator: Key Lessons from Current Meeting and Looking Towards the 2021 Workshop
Buck Institute on Aging, Novato, CA

 

Mark Kieran, MD, PhD
Scientific Organizing Committee
Moderator: Treatments and Trials on the Horizon
Bristol-Meyers Squibb

 

Martin Bergö, PhD
Karolinska Institutet, Stokholm, Sweden

 

Francis Collins, MD, PhD
RNA and DNA Therapeutics for Progeria
Director, National Institutes of Health, Bethesda, MD

 

Tom Misteli, PhD
Mechanisms and Therapeutic Applications in HGPS and Summation of Key Findings Panel
National Cancer Institute, National Institutes of Health, Bethesda, MD

 

Srinivasan Mukundan, MD, PhD
Clinical Cardio-Neurovascular Panel:
Brigham &Women’s Hospital, Boston

 

Francesco Musumeci, MD
Clinical Cardio-Neurovascular Panel: Aortic Valve Replacement for Progeria
Azienda Ospedaliera San Camillo Forlanini, Italy

 

Bum-Joon Park, PhD
Pusan National University, South Korea

 

Ashwin Prakash, MD
Clinical Cardio-Neurovascular Panel
Boston Children’s Hospital, Boston, MA

 

Pinak Bipin Shah, MD
Clinical Cardio-Neurovascular Panel: Aortic Valve Replacement for Progeria
Brigham and Women’s Hospital, Harvard Medical School